Gilead Lawsuit Over Truvada HIV Drug Patents Filed Against U.S. Government

The makers of the blockbuster HIV drug Truvada has filed a lawsuit against the U.S. government, claiming that the U.S. Centers for Disease Control and Prevention (CDC) breached a contract with Gilead, when it secured patents on the lucrative use of the drug to prevent the development of HIV.

Gilead announced the Truvada lawsuit in an April 24 press release, indicating that the U.S. government violated four Material Transfer Agreements (MTAs) and a Clinical Trial Agreement entered into by the company and the CDC.

The contracts were used to govern a collaboration that resulted in Truvada being used for pre-exposure prophylaxix (PrEP), and Gilead claims the contracts included provisions with a promise by the CDC not to seek patent protection on any inventions that came from the 15-year collaboration with the drug maker.


Were you or a loved one prescribed Truvada or other HIV drugs?

Gilead HIV drugs Truvada, Atripla, Stribild, Viread and Complera have been linked to increased risks of kidney and bones injuries. Lawyers are actively reviewing cases for individuals who have suffered injuries.

Learn More About this Lawsuit See If You Qualify For Compensation

The Gilead lawsuit claims the government violated that agreement when the U.S. Department of Health and Human Services filed for Truvada patent protection in 2006.

The case is the latest salvo between the federal government and Gilead, over who actually owns the patent for the HIV drug. In November 2019, the U.S. Department of Justice announced the filing of its own patent lawsuit against Gilead, indicating that the government spent hundreds of millions of dollars on clinical studies, and now Gilead is profiting by selling the drugs at highly inflated prices to the taxpayers who helped created it.

Gilead is allegedly infringing on four patents owned by the U.S. Department of Health and Human Services (HHS) through its sale of Truvada and Descovy as pre-exposure prophylaxix (PrEP), according to the lawsuit. The two HIV drugs are believed to be 99% effective at preventing the transmission of HIV when taken daily by those without the disease.

According to the lawsuit, Gilead originally obtained FDA approval for the drugs to be used in combination with other treatments. However, in the early 2000’s, researchers at the U.S. Centers for Disease Control and Prevention (CDC) created new regimens to prevent the spread of HIV. Those regimens were patented by the U.S. government.

Gilead then began to sell the drugs, emtricitabine and tenofovir, which had previously only been for treatment of already infected persons, as Trudava for PrEP, and has generated billions of dollars in sales among individuals who are at high risk of developing HIV.

Gilead’s response with this latest lawsuit claims the federal government’s lawsuit is invalid, because it should not have gotten the patents in the first place. The company’s attorneys claim it has suffered reputational harm and unnecessary legal fees due to the federal lawsuit and seeks a declaration of contract breach and compensatory damages.

In addition to the legal battle with the Justice Department, Gilead faces a growing number of individual Truvada lawsuits filed by users of the HIV drug who have experienced bone and kidney problems caused by tenofovir disoproxil fumarate (TDF) contained in the medication.

Those plaintiffs claim that Gilead knew about a safer alternative in 2004, known as tenofovir alafenamide (TAF), which is used in Descovy and other drugs introduced in recent years, yet held off on development of the newer drugs until Truvada and other TDF-based drugs started facing generic competition.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Master Baby Food Lawsuit Filed in MDL Outlines How Toxic Metals Caused Autism, ADHD in Children
Master Baby Food Lawsuit Filed in MDL Outlines How Toxic Metals Caused Autism, ADHD in Children (Posted today)

Plaintiffs have submitted a baby food lawsuit Master Complaint that is expected to streamline the filing of lawsuits alleging that toxic heavy metals in Beech-Nut, Gerber, Hain and Nurture products caused ADHD, autism and other developmental disorders.

Lawsuit Claims AGGA Device Damaged Teeth, Resulting in Disfiguring Injury
Lawsuit Claims AGGA Device Damaged Teeth, Resulting in Disfiguring Injury (Posted today)

Another AGGA device lawsuit has been filed by a man who says he had to have the device surgically removed less than a year after having it implanted due to jaw problems and migraines.